Page breadcrumb nav

VAERS Report 2156824

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-11-27
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

pain; restricted range of movement; numbness; tingling in little finger and ring finger; off label use; interchange of vaccine product; shoulder pain; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority. regulatory number: gb-mhra-webcovid-202202181054239110-zhebo. other case identifier(s): gb-mhra-adr 26619662. a female patient received bnt162b2 (comirnaty), administration date 27nov2021 (batch/lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "suspected covid-19", start date: 30dec2020 (unspecified if ongoing), notes: unsure when symptoms stopped; "steroid therapy" (unspecified if ongoing), notes: taking regular steroid treatment (e.g. orally or rectally); "asthma" (unspecified if ongoing). concomitant medication(s) included: qvar easi-breathe taken for asthma. vaccination history included: covid-19 vaccine astrazeneca, administration date: 15mar2021, for covid-19 immunisation; covid-19 vaccine astrazeneca, administration date: 31may2021, for covid-19 immunisation. the following information was reported: off label use (medically significant) with onset 27nov2021, outcome "unknown", described as "off label use"; interchange of vaccine products (medically significant) with onset 27nov2021, outcome "unknown", described as "interchange of vaccine product"; arthralgia (medically significant) with onset 27nov2021, outcome "not recovered", described as "shoulder pain"; pain (medically significant), outcome "unknown", described as "pain"; movement disorder (medically significant), outcome "unknown", described as "restricted range of movement"; hypoaesthesia (medically significant), outcome "unknown", described as "numbness"; paraesthesia (medically significant), outcome "unknown", described as "tingling in little finger and ring finger". the events "shoulder pain", "restricted range of movement", "numbness" and "tingling in little finger and ring finger" were evaluated at the physician office visit. the patient underwent the following laboratory tests and procedures: sars-cov-2 test: inconclusive test, notes: inconclusive test. clinical course: within hours of booster, the patient experienced severe pain in shoulder above vaccination site. three months later now and still have pain and restricted range of movement as well as numbness and tingling in little finger and ring finger on same side. the patient had a phone appointment with gp who was quite off hand and dismissive. the patient is not enrolled in clinical trial. the patient consulted an osteopath to try and gain more range of movement in shoulder as it is affecting daily life. "quarter inhaler daily" was reported. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
test name: covid-19 virus test; result unstructured data: test result:inconclusive test; comments: inconclusive test
Liste des symptômes
paraesthesia arthralgia pain movement disorder hypoaesthesia interchange of vaccine products sars-cov-2 test off label use
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na